Cargando…

Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country

OBJECTIVE: The aim of our study was to examine the prevalence of and factors associated with antipsychotic polypharmacy (APP) among patients with serious mental illness in the current South African health care context. METHODS: We collected data on patient, illness, and treatment characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, Kerryn S., Temmingh, Henk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111406/ https://www.ncbi.nlm.nih.gov/pubmed/28177063 http://dx.doi.org/10.1590/1516-4446-2016-2015

Ejemplares similares

The prevalence and clinical correlates of substance use disorders in patients with psychotic disorders from an Upper-Middle-Income Country
por: Temmingh, Henk S., et al.
Publicado: (2020)

The comorbidity conditions and polypharmacy in elderly patients with mental illness in a middle income country: a cross-sectional study⋆()
por: de Lima, Juliana Dias, et al.
Publicado: (2020)

Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
por: Younas, Mediha, et al.
Publicado: (2016)

Scoping review exploring vocational rehabilitation interventions for mental health service users with chronic mental illness in low-income to upper-middle-income countries
por: Chimara, Munyaradzi, et al.
Publicado: (2022)

Vocational rehabilitation for mental health service users with chronic mental illness in low-income to upper-middle-income countries: a scoping review protocol
por: Chimara, Munyaradzi, et al.
Publicado: (2021)

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
por: Llorca, Pierre Michel, et al.
Publicado: (2013)

Addressing Stigma Relating to Mental Illness in Low- and Middle-Income Countries
por: Mascayano, Franco, et al.
Publicado: (2015)

Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice
por: Jakobs, Kirsti M., et al.
Publicado: (2020)

Homelessness and severe mental illness in low- and middle-income countries: scoping review
por: Smartt, Caroline, et al.
Publicado: (2019)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness
por: Forma, Felicia, et al.
Publicado: (2020)

Findings from a Nationwide Study on Alcohol Consumption Patterns in an Upper Middle-Income Country
por: Robert Lourdes, Tania Gayle, et al.
Publicado: (2022)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Participation of Lower and Upper Middle–Income Countries in Clinical Trials Led by High-Income Countries
por: Rubagumya, Fidel, et al.
Publicado: (2022)

Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2018)

Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness
por: Valenstein, Marcia, et al.
Publicado: (2011)

Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature
por: Hughes, Nicole, et al.
Publicado: (2016)

Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2016)

Long‐term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
por: Kadra, G., et al.
Publicado: (2018)

Does financial inclusion control corruption in upper-middle and lower-middle income countries?
por: Barik, Rajesh, et al.
Publicado: (2022)

Editorial: Digital interventions and serious mobile games for health in low- and middle-income countries (LMICs)
por: Borda, Ann, et al.
Publicado: (2023)

Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes
por: Aakre, Jennifer M, et al.
Publicado: (2012)

Validating intrinsic capacity to measure healthy aging in an upper middle-income country: Findings from the ELSI-Brazil
por: Aliberti, Márlon J.R., et al.
Publicado: (2022)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Risk factors for serious outcomes associated with influenza illness in high‐ versus low‐ and middle‐income countries: Systematic literature review and meta‐analysis
por: Coleman, Brenda L., et al.
Publicado: (2017)

The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
por: Farrell, Christian, et al.
Publicado: (2020)

Severe mental illness and substance use disorders in prisoners in low-income and middle-income countries: a systematic review and meta-analysis of prevalence studies
por: Baranyi, Gergő, et al.
Publicado: (2019)

Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy
por: Yazici, Esra, et al.
Publicado: (2017)

A review of health worker vaccination programs in low, middle and upper middle-income countries()
por: Gaviola, Gabriel C., et al.
Publicado: (2023)

Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country
por: Butt, Muhammad Daoud, et al.
Publicado: (2022)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Home visits by community health workers to improve identification of serious illness and care seeking in newborns and young infants from low- and middle-income countries
por: Tripathi, A, et al.
Publicado: (2016)

In-service training for health professionals to improve care of seriously ill newborns and children in low-income countries
por: Opiyo, Newton, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fm22grh99jibrp2764mk85jrbq